A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN PEDIATRIC SUBJECTS WITH EPILEPSY WITH PARTIAL-ONSET SEIZURES PHASE 3
Clinical Trial Grant
Administered By
Pediatrics, Neurology
Awarded By
UCB Biosciences Inc.
Start Date
December 20, 2019
End Date
December 18, 2020
Administered By
Pediatrics, Neurology
Awarded By
UCB Biosciences Inc.
Start Date
December 20, 2019
End Date
December 18, 2020